The Caenorhabditis elegans mitochondrial (Mit) mutants have disrupted mitochondrial electron transport chain (ETC) functionality, yet, surprisingly, they are long lived. We have previously proposed that Mit mutants supplement their energy needs by exploiting alternate energy production pathways normally used by wildtype animals only when exposed to hypoxic conditions. We have also proposed that longevity in the Mit mutants arises as a property of their new metabolic state. If longevity does arise as a function of metabolic state, we would expect to find a common metabolic signature among these animals. To test these predictions, we established a novel approach monitoring the C. elegans exometabolism as a surrogate marker for internal metabolic events. Using HPLCultravioletbased metabolomics and multivariate analyses, we show that longlived clk1(qm30) and isp1(qm150) Mit mutants have a common metabolic profile that is distinct from that of aerobically cultured wildtype animals and, unexpectedly, wildtype animals cultured under severe oxygen deprivation. Moreover, we show that 2 shortlived mitochondrial ETC mutants, mev1(kn1) and ucr2.3(pk732), also share a common metabolic signature that is unique. We show that removal of soluble fumarate reductase unexpectedly increases health span in several genetically defined Mit mutants, identifying at least 1 alternate energy production pathway, malate dismutation, that is operative in these animals. Our study suggests longlived, genetically specified Mit mutants employ a novel metabolism and that life span may well arise as a function of metabolic state.-Butler, J. A., Ventura, N., Johnson, T. E., Rea, S. L. Longlived mitochondrial (Mit) mutants of Caenorhabditis elegans utilize a novel metabolism.
Only a small number of Mit mutants have been defined genetically, including clk1(qm30), isp1(qm150), tpk1(qm162), and lrs2(mg312) (8) . clk1 encodes a demethoxyubiquinone monoxygenase necessary for the synthesis of ubiquinone (9) . The qm30 allele produces no detectable protein product (10); however, clk1 mutants supplement their ubiquinone deficiency, in part, via nutritional sources (11) . isp1 encodes the Rieske ironsulfur protein of complex III, and the qm150 allele encodes a missense point mutation that reduces function of the protein product (12) . tpk1 encodes thiamine pyrophosphokinase (TPK), and the qm162 allele encodes a missense mutation (13) . Deficiency of TPK disrupts cellular thiamine levels and hence the ketoacid dehydrogenases that operate the mitochondrial tricarboxylic acid cycle and feed electrons into the ETC. lrs2 encodes mitochondrial leucine tRNA synthetase. The mg312 allele is maternaleffect viable, and the allele encodes a truncated, nonfunctional protein (2) . So far, only 2 genetically defined mitochondrial ETC mutations that shorten life span in C. elegans have been described: mev1(kn1), a missense allele in the gene encoding the cytochrome b subunit of complex II (14) , and gas 1(fc21), which encodes the 49kDa subunit of complex I (15) .
A recent study (16) has suggested that the mechanisms responsible for life extension in RNAiinduced Mit mutants differ from those in their genetically defined counterparts. Specifically, RNAi treatment against isp1 or the complex I gene nuo6 both invoked a mitochondrial unfolded protein response, along with an autophagic response. Genetically defined versions of these Mit mutants, namely isp1(qm150) and the newly defined nuo6(qm200), showed neither response. It was speculated that genetic mutants inhibited mitochondrial ETC flux without causing ETC supercomplex disruption and that this triggered a second, undefined mechanism of life extension.
In its natural soil environment, C. elegans is normally exposed to bouts of hypoxia (17) . In contrast to RNAidefined Mit mutants, ATP levels in genetically defined Mit mutants appear to be maintained at or above normal levels (16) . We have previously proposed that genetically defined Mit mutants utilize ATP production pathways normally reserved for survival during times of oxygen deprivation (4, 18) . Moreover, use of such alternate metabolic pathways may, in and of themselves, be responsible for life extension in these animals; that is, the precise configuration of metabolic processes used to operate Mit mutant cells may be the ultimate determiner of Mit mutant life span.
In the following work, we establish novel methodology to monitor metabolism in live C. elegans. We test whether genetically defined Mit mutants utilize nonoxygen requiring ATP production pathways and whether their extended life span is associated with a metabolic configuration that is unique.
MATERIALS AND METHODS

Nematode strains and maintenance
The following C. elegans strains were used: N2 Bristol, CL2166 [dvIs19pAF15(gst4: . All strains were maintained on standard NGM agar supplemented with Escherichia coli (OP50), as described previously (19) .
RNAi 1 Bx6
Bx5
Step 1: largescale nematode cultivation Feeding RNAi constructs targeting small fumarate reductase (F48E8.3), nuo2, and ucr2.3 were obtained from the Ahringer RNAi library collection (20) . For feeding RNAi, 2 methods were employed, our routine method, which we have described in detail previously (3) , and one based on the method of Timmons et al. (21) and designed for greater RNAi efficacy. For this method, RNAi clones were cultured for 16 h at 37°C in Luria broth supplemented with 100 μg/ml ampicillin and 12.5 μg/ml tetracycline. A 250μl aliquot was then seeded into 25 ml 2× YT broth (containing both antibiotics) and cultured for an additional 4 h at 37°C, after which isopropylβDthiogalactoside (IPTG) was added to a final concentration of 0.4 mM. The culture was then grown an additional 4 h at 37°C, after which the bacteria were pelleted, 21 ml of the supernantant was discarded, and fresh ampicillin, tetracycline, and IPTG were added to a final concentration of 100 μg/ml, 5 μg/ml, and 1 mM, respectively. Then, 200μl bacterial aliquots were seeded onto NGM agar plates containing analagous antibiotic and IPTG concentrations, dried overnight, and stored at 4°C. For both methods, the P generation was established by allowing 1dold N2 adults to lay eggs onto NGM/OP50 for 4 h, after which eggs were manually transferred to fresh RNAi lawns.
Anoxia resistance
Synchronous worm populations were established via a 4 h limited lay on NGM/OP50 plates. Onedayold gravid adults were then transferred to NGM/OP50 agar plates containing 25 μM 5fluoro2′deoxyuridine (FuDR) and incubated overnight to block progeny production. Animals were then collected and washed in Sbasal medium (100 mM NaCl and 50 mM KH PO , pH 6.0), resuspended in 200 μl Sbasal containing 100 μg/ml ampicillin, 25 μM FuDR, and in relevant instances 1 mM fumarate, 1 mM succinate, 1 mM malate, or 1 mM glucose. Animals were subsequently placed inside a sealed chamber (22) and continuously perfused with wet 0.05% CO /N . At various times, 120 animals/condition were removed, and percentage survival was scored following an overnight recovery period at 20°C on NGM/OP50 plates containing 25 μM FuDR.
Azide resistance
Onedayold adult worms were placed into a 20μl droplet of 500 mM NaN (5 animals at a time), and the time taken for each animal to become fully paralyzed was recorded. This concentration of NaN was chosen because it represented a balance between onset of paralysis and assay length.
Microscopy
Nomarski images were collected using a Zeiss Axioskop connected to a chargecoupled diode camera (Carl Zeiss, Oberkochen, Germany), as described previously (3).
Lifespan analyses
Collection and analysis of lifespan data have been described in detail by us previously (3) . Animals that bagged, desiccated, or suffered gonad extrusion were scored as censored individuals. Such animals were included in lifespan analyses up to the point of censorship and were weighted by half in mortality calculations.
Exometabolism analysis
We standardized our collection and analysis of the C. elegans exometabolism using the following procedure (biological replicates, or triplicates, were obtained for each strain).
The 25,000 synchronous eggs were prepared without the use of bleach, as described previously (23) , and then spotted onto NGM/OP50 plates supplemented with twice the standard peptone and OP50 concentrations (5000 eggs/plate; ref. 19 ). Eggs were cultivated at 20°C until reaching the first day of adulthood. Step 2: exometabolism collection
Step 3: HPLCultraviolet (UV) data collection
Step 4: chromatogram normalization
Step 5: chromatogram cropping
Step 6: chromatogram alignment
Step 7: chromatogram baseline subtraction
Step 8: peak modeling and integration
Step 9: generation and alignment of a combined peak table
Adult worms were collected and washed extensively in Sbasal to remove worm debris and bacteria (1 g, 5×50 ml). Bacteria attached to the cuticle were removed using the sucrose flotation method of Foll et al. (24) . After being washed extensively (400 g, 3×15 ml) to remove sucrose, worms were resuspended in Sbasal (1.4 ml final total volume) and then transferred to a 3.5cm glass petri dish (Kimax; Kimble Chase, Vineland, NJ, USA). Worms were placed inside a hydration chamber on an orbital shaker (100 rpm) and exposed for 18 h to either ambient conditions (22°C) or severe oxygen deprivation (continuous perfusion with 0.05% CO /N ). At the end of the incubation period, the exometabolomerich supernatant and worm fractions were separated by centrifugation (400 g), the supernatant was then filtered through a 0.2μm nylon filter (6502413X; Life Science Products, Frederick, CO, USA), and both fractions were stored at −80°C until further use.
On the day of analysis, 150 μl of each supernatant was thawed on ice and acidified with 0.5 μl of phosphoric acid (final pH≤2.5). Metabolites were then separated on a Waters 600 HPLC system (Waters Corp., Milford, MA, USA) using a Prevail organic acid column (5 μm particle size, 4.6×150 mm; Grace Discovery, Deerfield, IL, USA) with a Prevail organic acid guard column (5 μm particle size). Specific run conditions were 100μl manual sample injection, mobile phase: 25 mM KH PO acidified to pH 2. UV chromatograms were normalized against total worm protein.
Briefly, the pellets in step 2 were vacuum desiccated, resuspended in 1 ml boiling 1% SDS, boiled for 5 min, and then vortexed and reboiled for an additional 5 min. Total protein was quantified using the BCA colorimetric assay (23225; Pierce, Rockford, IL, USA). All chromatograms were scaled using Clarity software to the equivalent of 1 g total worm protein.
Normalized chromatograms were exported into the program SpecAlign (v2.3; Jason Wong, Oxford University, Oxford, UK) and then cropped to run times between 1.5 and 20 min.
HPLC experiments were performed over the course of 18 mo. Due to minor differences in chromatographic runs, chromatograms had to be aligned before peak decomposition and integration could be performed for multivariate analysis. Alignment was accomplished using SpecAlign. Briefly, a representative chromatogram from each strain was chosen against which all replicates were aligned. Representative templates were then sequentially aligned against each other. Alignment was intensely supervised. In general, the combined RAFFT/Peak algorithm of SpecAlign worked best for peaks eluting before 10.5 min and the RAFFT algorithm worked best for those eluting later.
Baselines were subtracted from chromatograms using the program Fityk (http://www.unipress.waw.pl/fityk/). Negative values were removed by writing a new function in the function editor of Fityk [Y=y−min(y)].
Most chromatogram peaks were modeled using the PseudoVoigt algorithm of Fityk, which incorporates elements of gaussian and lorentzian curves. Fityk's SplitGaussian curvefitting function was used for large, earlyeluting peaks (<1.8 min). Closely eluting peaks were manually fitted.
Peak tables were combined into a single spreadsheet, then peak retention times were manually fine aligned. Specifically, peaks assigned by SpecAlign that eluted within 3 s of each other were binned under a single retention time. A total of 900 Step 10: spurious peak filtering
Step 11: missing data estimation
Step 12: cluster analysis
Step 13: data transformation
Step 14: PCA
Step 15: electrospray ionization (ESI) mass spectrometry peak entries was defined (summed across all samples; untransformed peak data are presented as Supplemental Data).
Peaks that were only observed in 1 sample (among all replicates) were considered spurious and removed from further analysis.
Not all peaks were present in every strain; 285 (out of 900) positions in the spreadsheet of peak areas contained "missing data." Four types of peaks with missing data were encountered: 1) peaks that were unique to 1 strain; 2) peaks that were restricted to specific strains but which were absent in some replicates; 3) peaks that were spuriously present in multiple strains; and 4) peaks that were reliably present in every strain except one. Eighty percent of the missing peak data fell into categories 1 and 3. For the purposes of this study, we assumed that all missing data fell below the limits of detection. (We note there could have been instances where a large neighboring peak may have enveloped a peak of interest and hence masked our ability to resolve it in step 8. These are possibly the cause of category 2 missing peaks). Missing data were treated in one of two ways, depending on the analysis being performed. For cluster analysis, data was imputed by inserting a value equal to 0.1 the signal of the smallest peak area above background. For PCA, missing data were handled as described in step 13.
Cluster analysis was performed using hierarchical clustering in the GenePattern toolbox (25) . Pearson correlation and pairwise completelinkage settings were chosen for all analyses.
The relative abundance of metabolites differed markedly within each strain (peak amplitude variation). The degree of variation of each metabolite, across strains, also varied (peak variance was not equal). For principal component analysis (PCA), these differences were minimized by transforming peak area data. After testing several strategies, we found that a modified rankordering procedure, followed by mean centering of the transformed data, gave the most satisfactory results in terms of not unduly inflating variance. Briefly, for each metabolite, peak area data was rank ordered across strain. For those metabolites with missing data, empty cells were assigned an equal rank X according to Eq. 1:
where n is the number of missing data points for the jth peak. All remaining nonzero peak areas were assigned a rank starting from (n +1). The transformed data were then mean centered, ready for PCA. We discovered that this method obviated the need for unit variance transformation, since rank transformation constrained the variance, and Eq. 1 had the effect of slightly downweighting peaks restricted to 1 or, at most, 2 strains.
PCA was performed using the function prcomp in the statistical program R (v2.6.0, http://www.rproject.org/). Numerical results are provided as Supplemental Data.
Peaks that were flagged by PCA for further analysis were reisolated following steps 1-3 above using HPLCgrade water (pH 2.5, using Trace grade HCl). Fractions from 3 runs were pooled, vacuum desiccated, and then immediately before analysis resuspended in methanol. All peaks were analyzed using an Applied BioSystems API QSTAR Pulsar i Hybrid LC/MS/MS (negative ESI mode, 3500 V; Applied Biosystems, Foster City, CA, USA). Step 16: enzymatic assay
Go to:
Pyruvate was detected in exometabolism samples using lactate dehydrogenase (LDH) in conjunction with HPLC. Briefly, 1 μl of 150 U/ml LDH was mixed with 10 μl of 2.25 mM NADH and 140 μl of the supernatant was collected in step 2. Samples were incubated at room temperature for 3 min, then acidified with 0.75 μl phosphoric acid, and immediately analyzed by HPLC, as described above.
Additional statistical analyses
All other statistical analyses were undertaken using either R (v2.7), Sigma Plot (v11.0; Systat Software, Inc., San Jose, CA, USA), or Microsoft Excel (v12.2.0; Microsoft, Redmond, WA, USA). Specific details are described in figure legends.
RESULTS
Mit mutants are resistant to chronic oxygen deprivation
C. elegans is a facultative anaerobe, and wildtype animals can survive up to 3 d of severe hypoxia (24, 26) . If Mit mutants constitutively supplement their mitochondrial ETC with alternate, nonoxygen requiring energygenerating pathways, then we would expect them to be less sensitive to the effects of severe oxygen deprivation. Consistent with this notion, we observed that 5 genetically defined Mit mutants [clk1(qm30), clk1(e2519), tpk1(qm162), lrs2(mg312), and isp1(qm150)] were markedly more resistant to the effects of severe oxygen deprivation than wildtype animals (Fig. 1A) . After 48 h of continuous perfusion with 0.05% CO /N , when all wildtype animals were dead, >70% of each Mit mutant remained alive. In the case of clk1(qm30) mutants, all animals remained alive; moreover, by 72 h (the end of the assay) only 5% of clk1(qm30) mutants had died. Survival of clk1(qm30) mutants was on par with long lived daf2(e1370) mutants, which are known to be resistant to both hypoxia (<1% oxygen) and anoxia (<0.003% oxygen; refs. 26, 27) . Shortlived ucr2.3(pk732) mutants also showed substantial oxygen deprivation resistance (this new mutant will be described in detail below), but, surprisingly, mev1(kn1) mutants, which are also short lived, showed only marginal resistance to severe oxygen deprivation. Reduction in physiological rates was not a prerequisite for resistance to oxygen deprivation: longlived, dietaryrestricted eat2(ad465) mutants showed only marginal resistance to oxygen removal.
Fermentation substrates are not limiting for survival under chronic oxygen deprivation
We tested whether the ability of clk1(qm30) and isp1(qm150) Mit mutants to survive chronic oxygen deprivation was limited by the availability of fermentation substrates. We supplemented wildtype, clk 1(qm30), and isp1(qm150) animals with various substrates during acute oxygen deprivation, including glucose, fumarate, malate, or succinate. We observed no enhancement of survival of any strain (Fig. 1B) . On the contrary, isp1(qm150) mutants appeared slightly less tolerant of severe hypoxia when cultured on any of these 4 carbon sources than when cultured in their complete absence. Nonetheless, under all 5 incubation conditions, we consistently observed enhanced survival of clk1 and isp1 mutants relative to wildtype animals.
Mit mutants are resistant to mitochondrial complex IV inhibition
Azide anion, N , is a potent inhibitor of cytochrome c oxidase, with a reported K for the bovine enzyme of 64 μM (28) . In worms, NaN is widely used to induce paralysis and to simulate hypoxia (27, 29); however, millimolar concentrations are required to transit the largely impermeable worm cuticle. We selected several different Mit mutants and measured the duration it took individual 1dold adult animals to stop moving following exposure to 500 mM NaN . We observed that all Mit mutants tested, including isp 1(qm150), lrs2(mg312), clk1(e2519), clk1(qm30), tpk1(qm162), and RNAiinduced nuo2 Mit mutants, were differentially resistant to the effects of azide administration relative to control animals (Fig. 1C) . These differences were significant, despite the increased variance in most Mit mutant populations. We also observed that the resistance phenotype of both isp1 and clk1 animals was robust to changes in genetic background (Fig. 1C , compare strains 4 and 5, left panel, and strains 3 and 4, right panel). Shortlived mev 1(kn1) mutants showed mild resitance to the effects of azide (though this did not reach significance), while ucr2.3(pk732) mutants showed no enhancement over wildtype, and eat2(ad465) were noticeably hypersentive to azide exposure. Consistent with previous hypoxiaresistance studies (27) , daf2(1370) mutants, but not age1(hx546) mutants, showed marked resistance to azide treatment.
In summary, using 2 different assays, and multiple genetic lesions, we show that Mit mutants consistently show resistance to procedures that normally limit ATP production by the mitochondrial ETC. We interpret these data to suggest that Mit mutants utilize nonoxygen requiring ATP production pathways to supplement their energy needs.
Removal of soluble fumarate reductase enhances Mit mutant survival
Many fermentation reactions function in the absence of oxygen to generate ATP and maintain redox balance. Malate dismutation is one such process and soluble fumarate reductase (sFR) functions in this pathway to catalyze the NADH/FADH dependent reduction of fumarate to succinate. In the yeast Saccharomyces cerevisiae, sFR activity is essential for growth and survival during anaerobia (30).
F48E8.3 encodes the sole soluble fumarate reductase in worms (18) . We tested the role of this enzyme in the lifespan specification of long and shortlived mitochondrial mutants (Fig. 2) . Unexpectedly, we found that removal of sFR significantly (logrank test, P<0.005) increased the survival of isp1(qm150) mutants relative to vector controltreated animals ( Fig. 2A) . tpk1(qm162) and clk1(e2519) mutants both showed marginally significant (logrank test, P<0.2) lifespan extension also ( Fig. 2A) . Wildtype animals showed a significant (logrank test, P<0.02) lifespan decrease ( Fig. 2A ); while mev1(kn1) and ucr2.3(pk732) showed either marginal life shortening or no response at all. When we inhibited sFR in clk1(qm30) animals, using a feeding RNAi method that was more potent than in the previous assays (21), we also observed lifespan lengthening (Fig. 2C ). This effect was not observed in wildtype animals (Fig. 2C) . To highlight the differential effects of sFR removal on Mit mutant survival, we have plotted the mean life span data from Fig. 2A , C in Fig. 2B , D, respectively. Data for an intermediate dose of sFR RNAi (1/10 dilution), which were collected at the same time as the other survival data, are also included in Fig. 2B .
During our studies with sFR, we noted that the fertility of all tested strains appeared to be enhanced (this data was not quantified). We have previously observed, using fluorescently tagged reporter strains, that both isp1(qm150) and clk1(qm30) Mit mutants have what we term a "cryptic bagging" phenotype (Cry), where a single egg hatches inside the mother, and eventually the progeny emerges at a later date through the vulva. The extent to which the mother is damaged during this process remains unclear. We therefore tested whether the lifespan increase we observed following sFR RNAi in isp1(qm150) and clk1(qm30) Mit mutants was simply a consequence of reduced cryptic bagging. Progeny production was inhibited using 25 μM 5fluoro2′deoxyuridine (FuDR) and then life span was rescored for each strain. Both isp 1(qm150) and clk1(qm30) Mit mutants differentially responded with an increase in mean, but not maximum life span (i.e., increased health span), while N2, ucr2.3(pk732), and mev1(kn1) mutants showed no or only marginal effects on maximum or mean life span (Fig. 2E, F) . We conclude that Mit mutants utilize sFR in a manner that normally acts to limit their surival potential.
ucr2.3 is a newly defined shortlived mitochondrial mutant
Adopting a candidate gene approach to identify ATPproducing metabolic pathways operative in Mit mutants is limited in its scope and capacity. Therefore, as detailed in the following sections, we established a novel, HPLCbased approach to test further our hypothesis that Mit mutants utilize nonoxygen requiring 2 ATP production pathways. Simultaneously, this approach also permitted us to test aspects of our second hypothesis, that longlived Mit mutants adopt a common metabolic state.
We focused our attention on longlived clk1(qm30) and isp1(qm150) Mit mutants, which ultimately affect complexes II and III, respectively (31, 32) , and shortlived mev1(kn1) and ucr2.3(pk732) mutants, which also affect complexes II and III, respectively (33) . ucr2.3 is 1 of 3 genes in C. elegans (along with ucr2.1 and ucr2.2) that show partial functional redundancy with each other and that encode a protein orthologous to human UQCRC2, a core subunit of mitochondrial complex III (34) . The ucr2.3(pk732) allele encodes a G51R missense mutation that was initially identified in an EMS screen for reversion of germline silencing of the Tc1 transposon (35, 36) . We now report that ucr2.3(pk732) is phenotypically indistinguishable from mev1(kn1) in terms of its reduced life span (Figs. 2E and Fig. 3) , its wildtypelike rate of growth and development, its propensity for vulval extrusion later in life, and its darker pigmentation (not shown). Similar to what we (3) have previously observed when treating N2 animals with a mev1 feeding RNAi construct, a feeding RNAi construct targeting ucr2.3 was also incapable of extending the N2 life span, even over 5 consecutive generations of continuous feeding (not shown). We therefore define ucr2.3(pk732) as a novel shortlived mitochondrial ETC mutant and distinguish mev 1(kn1) and ucr2.3(pk732) mutants from Mit mutants by describing their phenotype as "Byby" (pronounced byebye, in reference to their shortlived phenotype).
Metabolic fingerprinting distinguishes Mit mutants from Byby mutants
At present, there is no clear understanding as to why genetically encoded Mit mutants are long lived. Several researchers (37, 38) have shown that there is a transriptional response activated following ETC disruption, but how this translates into long life is far from clear. A fundamental hypothesis is that longevity arises as a function of metabolic state. That is, the rerouting of metabolites through core metabolic pathways may place cells in a state that is simply conducive to a long life. If true, we would predict that the intermediary metabolism of Mit mutants should be very similar. The corollary, that "shortivity" is a function of a separate metabolic state, may also be true. To test these ideas, we established a novel approach using HPLCUV chromatography in conjunction with multivariate analyses to monitor the exometabolism of isp1(qm150), clk1(qm30), mev1(kn1), and ucr2.3(pk732) mutants. The C. elegans exometabolism provides a proxy of internal metabolism and consists of end product metabolites. It is distinct from defecated intestinal waste products that, in our experiments, were emptied from the gut during the washing steps before analysis (refer to Materials and Methods and see also Discussion). As controls, we also collected the exometabolome of wildtype animals (N2) cultured under normoxic and, seperately, severely hypoxic (anoxic) conditions. Exometabolome samples were fractionated using an organic acid HPLC column. Clear differences in chromatographic profiles across strain and condition were evident (representative exometabolome profiles are shown in Fig. 4A ). Notably, differences in peak retention time or peak intensity, or both, differentiated strains. Surprisingly, when we integrated metabolite levels within each strain and used this as a proxy of metabolic activity (this approach does not take into account differences in UV absorbance between different metabolites), we observed a marked increased in the amount of metabolites excreted by Byby mutants relative to normoxic wildtype animals (Fig. 4B) . In contrast, we observed a marked decrease in the amount of metabolites excreted by wildtype animals cultured under severe oxygen deprivation. The amount of metabolites excreted by clk1(qm30) Mit mutants was relatively unchanged compared with normoxic, wildtype animals, but production was reduced by half in isp1(qm150) animals (Fig. 4B ).
Marked similarities in the metabolic profiles of each pair of long and shortlived mitochondrial ETC mutants were also evident. Support for this observation became obvious using PCA. In our analysis, 70% of the variance across all samples was described by the first 3 principal components (PCs, Fig. 4C ). Plotting these new variables confirmed that longlived Mit mutants produced metabolic end products distinguishable from those produced by shortlived mitochondrial mutants and distinguishable again from those generated by wildtype animals cultured under either normoxia or severe oxygen deprivation (Fig. 4  D) .
To independently confirm that the clustering in Fig. 4D did not arise simply because of differences in intensity of profiles (rather than a differential profile of peaks), we used a hierarchicalclustering approach that was insensitive to changes in peak profile intensity (Materials and Methods). We observed an identical clustering pattern of strains (Fig. 5) .
Pyruvate production is increased in Mit mutants
We sought to determine the identity of the metabolites driving the separation of Mit from Byby mutants. Figure 6A shows the relative contribution of each chromatographic peak to PC1, PC2, and PC3. We selected some of the largestcontributing peaks and subjected them to analysis by ESI mass spectrometry. Most peaks contained multiple metabolites and hence require additional analysis to be further informative. Two peaks stood out in our analysis. The first was the peak of pyruvate alone, which we also confirmed enzymatically and which was significantly increased in the 2 longlived Mit mutants relative to wildtype animals (t test, P<0.01; Fig. 6B; Supplemental Table 1 ). Another signficant peak was enriched in short lived Byby mutants; it contained a complex mixture of metabolites, including lactate, αketoglutarate, and the dipeptide GlyPro (Fig. 6C) .
DISCUSSION
In the present study, we sought to gain insight into the metabolic processes mediating life extension in the Mit mutants. We hypothesized that Mit mutants supplement their mitochondrial ETC deficiencies by exploiting alternate ATP production pathways that do not require oxygen as a terminal electron sink, and that longevity is a property that arises out of the way metabolic networks are configured. Our findings revealed that several Mit mutants, including clk1(qm30), clk1(e2519), tpk1(qm162), lrs2(mg312), and isp1(qm150), display marked resistance to severe oxygen deprivation as well as to hypoxia. Our findings also revealed that soluble fumarate reductase played an unexpected role in significantly limiting the life span potential of clk1(qm30) and isp1(qm150) Mit mutants. These findings support the idea that alternate ATP production pathways are operative in Mit mutants and that alterations in fumarate metabolism can have significant effects on life span, depending on strain background. Using the C. elegans exometabolome as a proxy for internal metabolic events, we also showed that clk1(qm30) and isp 1(qm150) Mit mutants are metabolically more similar to each other than to either aerobically or anaerobically cultured wildtype animals. The metabolism in these mutants also appears markedly different from that operative in shortlived mev1(kn1) and ucr2.3(pk732) Byby mutants. Our findings support the notion that life span, per se, may indeed be a fundamental property of metabolic configuration.
In our studies on low oxygen tolerance, we tested 2 conditions that were relatively easy for us to achieve: severe oxygen deprivation and psuedohypoxia. Oxygen concentrations in our oxygendeprivation chamber were below the limit of detection of a Clarketype oxygen electrode. It is likely, therefore, that worms incubated under these conditions were exposed to near anoxia. Mendenhall et al. (26) showed that daf 2(e1370) mutants can survive exposure to anoxia for ≥5 d. Resistance was dependent on daf16 as well as the glycolytic enzymes glyceraldehyde3phosphate dehydrogenase2 and 3 (gdp2 and gpd3). Surprisingly, RNAimediated removal of other glycolytic enzymes did not affect the anoxia resistance of daf2(e1370) mutants. Recent microarray studies have shown that gpd2 and gpd3 are both elevated in clk1(qm30), isp1(qm150), and cco1 (RNAiinduced) Mit mutants (37) . It is likely that gpd2/3 played an integral role in the resistance of Mit mutants to anoxia in the current study.
Sodium azide was previously employed to simulate hypoxic conditions in worms (27) . In our assay for sensitivity to hypoxia, we treated a variety of Mit mutants with sodium azide and observed that every one showed significant resistance to paralysis. Given the uniform resistance of Mit mutants to hypoxia, it is possible that HIF1 is active in these animals. Hypoxiainducible factor1 (HIF1) is a conserved transcription factor that is one of the primary effectors of hypoxia sensation in C. elegans (39) . Of the 110 genes known to be upregulated following hypoxia exposure, 63 require hif1 activity (40) . At least 3 mechanisms are known to modulate hif1 and resistance to hypoxia in worms: inhibition of the daf2/akt 1/pdk1/daf16 pathway (27); germline sterility, which acts independently of hif1 and daf16 (41); and translational retardation, which appears to regulate the level of activation of the unfolded protein response (42) . Whether inhibition of the mitochondrial ETC represents a fourth, novel pathway remains unclear. Nonetheless, our findings raise the exciting possibility that reducing flux through the mitochondrial ETC, at least in the manner employed by Mit mutants, may also prove beneficial in humans during, or while recovering from, hypoxic stress such as stroke.
To what extent hif1 plays a role in Mit mutant life extension remains to be determined, but it is interesting that overexpression of hif1 extends the life span of wildtype animals (43,-45) . Augmentation of HIF1 transcriptional activity may in fact be the reason inhibition of soluble fumarate reductase increased the life span of clk1(qm30) and isp1(qm150) Mit mutants in the present study. Specifically, EGL9 is a prolyl 4 hydroxylase that hydroxylates 2 proline residues in HIF1 in an oxygen and αketoglutaratedependent manner. Under normoxic conditions, formation of these modified residues directs VHL1, an E3 ubiquitin ligase, to degrade HIF1. Fumarate is a competitive inhibitor of αketoglutarate in the EGL9 reaction (46) . Although a role for hif1 in Mit mutant life extension is an intriguing notion, at this point we cannot rule out the alternate possibilty that sFR acts as a redox sink in Mit mutants and that when it is inhibited, NADH/FADH reducing equivalents are funneled down other metabolic pathways resulting in unknown, beneficial effects.
Presently, we remain uncertain why Byby and Mit mutants respond so differently to anoxia, hypoxia, and loss of sFR. Unlike Mit mutants, we observed that mev1 mutants were mostly intolerant of anoxia, showed marginal resistance to hypoxia, and were unaffected by the loss of sFR. ucr2.3 mutants, on the other hand, were quite resistant to anoxia but showed zero tolerance of hypoxia and little or response to loss of sFR. These functional differences between Mit and Byby mutants underscore their obvious differences in life span and are in agreement with our HPLC results that showed there were overt differences in the metabolites excreted by Mit and Byby mutants, both in terms of the type of metabolites they made and their overall level of metabolic activty (absolute signal abundance).
Very little is known about the lifeextending mechanisms operative in Mit mutants. Recent evidence suggests p53/cep1 is partially responsible for the process (47) . Oxidative stress, bioenergetic stress, or ER or mitochondrial unfolded protein stress may all play a role in Mit mutant longevity (4, 6) , although several studies now challenge the role of oxidative stress (2, 3, 48) . Genetic epistasis studies have led to the tentative conclusion that Mit mutant longevity occurs independently of the daf2/daf16 pathway (1, 2, 47, 49) and that it is synonymous with dietary restriction or at least it uses some of the same mechanistic processes (50, 51) . In the current study, we bypassed questions regarding what processes might be activated in Mit mutants to signal longevity specification and instead we focused our efforts on identifying the end result of such changes. We asked the simple question, are discrete metabolic configurations associated with different life span outcomes; do the Mit mutants adopt a metabolic configuration that is unique? We made no assumptions about whether such changes are programmed or whether they occur simply as a consequence of metabolite rerouting, although we hypothesized that the latter may well be the case. Our data support the conclusion that longlived Mit mutants do indeed adopt a novel metabolic configuration that is different from that of shortlived Byby mutants and different again from that of wild type animals cultured under normoxia. Surprisingly, there was very little overlap between the metabolic profile of Mit mutants and wildtype animals exposed to severe oxygen deprivation. It will be interesting to determine if the exometabolome profiles of Mit mutants and wildtype animals converge when the latter is exposed to less severe oxygen deprivation.
We chose to analyze the C. elegans exometabolome for the current study because it is less complex than the entire worm metabolome. A recent systems biology investigation using S. cerevisiae showed that the exometabolome could be used to reliably predict internal metabolism (52) . We collected exometabolites following an 18 h incubation in minimal media. Under excess food conditions, C. elegans can passage material through its gut in <2 min (53) . It is almost certain that our worm populations entered a state of starvation sometime during their 18 h incubation period. It is possible that the exometabolome profiles we identified that separate Mit from Byby mutants simply reflect differences in their rate of progression into starvation. Against this idea, however, our pilot studies illustrated that between 30 min (the earliest time point we could access) and 18 h there was little change in the profiles of metabolite peaks; only the magnitude of metabolite peaks increased. Based on these findings, we favor the notion that the metabolic profiles we have observed reflect bonafide alterations in pathways that fuel life in long and shortlived mitochondrial mutants. The differential accrual of pyruvate by Mit mutants, but of lactate, αketoglutarate, and GlyPro by Byby mutants, also supports this idea.
Three recent studies support our current observations showing that longlived Mit mutants adopt a common metabolic configuration. Cristina et al. (37) recently explored the transcriptional alerations that occur in clk1(qm30), isp1(qm150), and RNAiinduced cyc1 Mit mutants. Relative to wildtype animals, clk1(qm30) and isp1(qm150) mutants both showed expression changes in ∼5% of the genome. In cyc1 mutants, some 30% of the genome displayed significant expression alterations. Remarkably, at an individual gene level, there was little overlap between the expression profiles of these 3 mutants; only 73 genes showed coalteration. Using GO term analysis, however, the researchers found that all 3 mutants likely exist in a closely related metabolic state akin to that invoked by activation of the retrograde response in petite Saccharomyces cerevisiae (54) . This metabolic state was characterized at the mRNA level by elevated expression of genes involved in glycolysis, anapleuerosis, mitochondrial ETC compensation, amino acid metabolism, xenobiotic detoxification, and peroxisomal fat metabolism. Our HPLC data now provide strong support for the idea that clk1(qm30) and isp1(qm150) do in fact reach the same metabolic end state.
In a second study, Falk et al. (38) analyzed the transcriptional alterations occurring in several mitochondrial mutants, including the shortlived gas1(fc21) mutant. Surprisingly, these researchers found that many of the biochemical processes transcriptionally altered in longlived Mit mutants were also altered in gas1(fc21) mutants. This is unexpected in light of our present findings, where we have shown that Mit and Byby mutants differ markedly at the level of their exometabolome. We can think of 3 possible interpretations to explain the gas1(fc21) observation: the transcriptome does not accurately reflect the intracellular metabolome; the exometabolome does not accurately reflect the intracellular metabolome; and gas1(fc21) is a Mit mutant, not a Byby mutant. With respect to the latter notion, Hartman et al. (55) reported that the maximum life span of gas1(fc21) mutants could in fact be extended beyond that of wild type animals simply by growing the animals at 15°C. It is possible that gas1(fc21) represents a class of genetically defined Mit mutants that are unable to fully stablize their ETC supercomplexes, even though they have the potential to be longlived Mit mutants. Low temperatures could enhance their ETC supercomplex formation to reveal their latent Mit phenotype. A corollary of this prediction is that other genetically defined Mit mutants should be identifiable when screened at lower temperatures. Moreover, mild hypothermia may be a novel form of treatment for some human patients with mitochondrial ETC disorders.
The third study that supports our contention that longlived Mit mutants adopt a common metabolic configuration relates to the work of Fuche et al. (56) , who used H nuclear magnetic resonance spectroscopy, in conjunction with microarray analyses, to map the intracellular metabolome of longlived dauers, several daf2 mutants, and a translationdefective ife2 mutant. Surprisingly, all these animals presented with a metabolic profile that was almost identical. Marked changes in lipid, carbohydrate, and amino acid catabolic pathways were observed. It remains to be seen whether this longevityassociated metabolic state is the same as the one we have now detected in Mit mutants. Go to:
Go to:
The concept of longlived organisms adopting an altered metabolism has been hinted at previously by microarray studies of several organisms (53,-55) , as well as by proteomic (57), amino acid (49) , and now metabolomicbased studies (56) . The novelty of our present study is that we have used an unbiased metabolomic approach to identify the first metabolic signatures able to distinguish longlived mitochondrial ETC mutants from shortlived mitochondrial ETC mutants. We have also been able to distinguish both classes of mutants from wildtype animals. Future studies will be aimed at fully characterizing this profile at the single metabolite level.
Supplementary Material
Supplemental Data: HPLCUV and PCA analysis of excreted metabolites differentiates longlived Mit mutants from shortlived Byby mutants. A) Excreted metabolites were collected and analyzed from N2 wildtype animals, longlived isp1(qm150) and clk1(qm30) Mit mutants, and shortlived mev1(kn1) and ucr2.3(pk732) Byby mutants, using HPLCUV, as described in Materials and Methods. Metabolites were also collected from N2 animals cultured under severe hypoxia. Representative HPLCUV traces for each strain/condition are shown. B) A crude measure of metabolic activity in each strain was obtained by integrating the area under each trace and averaging across replicates (means±SE). Anerobic N2, isp1(qm150) and mev1(kn1) were significantly different from N2. P < 0.05; Student's t test. C) Chromatogram peak areas in each trace were modeled using the pseudovoigt peakfitting algorithm of the program Fityk. PCA analysis was then performed using R on the set of all peaks, over all strains. Shown is a scree plot of the resulting PCs; 70% of the variance in the excreted metabolite data is captured by the first 3 PCs. D) Plot of PC1, PC2, and PC3 scores for each strain shows that long and shortlived Mit mutants can be differentiated on the basis of their metabolic end products (solid squares, N2; shaded squares, anaerobic N2; solid circles, clk1(qm30); shaded circles, isp1(qm150); solid triangles, mev1(kn1); shaded triangles, ucr2.3(pk732). 
